Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | PDCD1LG2 | Q9BQ51 | 2/20 | 0.45 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.45 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 4/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 5/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22720995 | 0.83 | MEN1 (0.60) | MEN1KMT2APDCD1LG2CD274HSD11B1 | |
| SCHEMBL28528305 | 0.80 | MEN1 (0.44) | MEN1KMT2APDCD1LG2CD274CHRM2 | |
| SCHEMBL31444559 | 0.80 | MEN1 (0.44) | MEN1KMT2APDCD1LG2CD274CHRM2 | |
| SCHEMBL31738967 | 0.79 | MEN1 (0.43) | MEN1KMT2APDCD1LG2CD274CHRM2 | |
| SCHEMBL31444531 | 0.79 | MEN1 (0.43) | MEN1KMT2APDCD1LG2CD274CHRM2 | |
| SCHEMBL29588230 | 0.79 | MEN1 (0.43) | MEN1KMT2APDCD1LG2CD274CHRM2 | |
| SCHEMBL22455759 | 0.79 | MEN1 (0.43) | MEN1KMT2APDCD1LG2CD274CHRM2 | |
| SCHEMBL839974 | 0.79 | CHRM5 (0.44) | MEN1KMT2ACHRM2CHRM5CHRM3 | |
| SCHEMBL1051987 | 0.79 | CHRM5 (0.44) | MEN1KMT2ACHRM2CHRM5CHRM3 | |
| SCHEMBL29394965 | 0.79 | CHRM5 (0.44) | MEN1KMT2ACHRM2CHRM5CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025072451-A1 | RAS-PI3K INHIBITORS FOR THE TREATMENT OF CANCER AND IMMUNOLOGICAL DISEASES | VIVIDION THERAPEUTICS, INC. (US) | 2025-04-03 | — | — | WO | disclosed |